Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy


  • Primary Biliary Cirrhosis — Profiles in PBC: Management Strategies for the Unmet Medical Need – Satellite Symposium
  • Chronic liver diseases, such as primary biliary cholangitis (PBC), are the leading cause of morbidity and mortality in the United States. PBC is associated with significant disease burden and unmet medical needs with regard to treatments. There is much excitement today within the medical community about ... more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD
  • Gynecologic Cancers — Treatment of Platinum-Resistant Recurrent Ovarian Epithelial Cancer – Case Study
  • Women with recurrent ovarian cancer have limited treatment options and a poor prognosis. This case illustrates the real-life scenario of a woman who experiences platinum-resistant recurrent ovarian cancer and addresses the treatment options, including the use of the targeted antiangiogenic agent bevacizumab, ... more >>
    B. Monk, MD, FACOG, FACS
  • Lung Cancer — Chapter 5.1: Non-Small Cell Lung Cancer: Recent Advances in Immunotherapy and Immune Biomarkers – @Point of Care Chapter
  • Traditionally, lung cancer has not been thought to be responsive to immunotherapy but a better understanding of the immune system has shown this to be a fallacy. Furthermore, emerging immunotherapies, including checkpoint inhibitors, are demonstrating impressive response rates in a substantial proportion of ... more >>
    T. Stinchcombe, MD
  • Lung Cancer — Chapter 1.1: Epidemiology of NSCLC: Current and Future Perspectives – @Point of Care Chapter
  • Chapter 1 focuses on the epidemiology of non-small cell lung cancer, including molecular epidemiology, risk factors, prevention, and gender-specific trends. Throughout this chapter you will find supportive multimedia hyperlinks that provide access to videos, journal articles, and other resources to enhance ... more >>
    M. Socinski, MD
  • Lung Cancer — Chapter 3.1: Diagnosis and Prognosis of NSCLC – @Point of Care Chapter
  • Previous chapters of the Non-Small Cell Lung Cancer @Point of Care program introduced non-small cell lung cancer (NSCLC), including its epidemiology and its molecular and genetic pathogenesis. This chapter focuses specifically on the diagnosis and prognosis of NSCLC, including screening recommendations, ... more >>
    T. Stinchcombe, MD
  • Lung Cancer — Chapter 4.2: Approved Targeted Agents – @Point of Care Chapter
  • Patients diagnosed with non-small cell lung cancer (NSCLC) now have treatment options beyond traditional chemotherapy. Targeted small molecules and monoclonal antibodies, selected based on a tumor’s histologic and molecular subset, offer improved efficacy profiles and tolerability. These therapies are ... more >>
    T. Stinchcombe, MD
  • Clinical Context: Gynecologic Cancers
  • Clinical Context: Gynecologic Cancers is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in gynecologic cancers. The curriculum includes case studies at the point of care and MedPage ... more >>
    B. Monk, MD, FACOG, FACS
  • Clinical Context: COPD
  • Clinical Context: COPD is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of COPD. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that will ... more >>
    B. Make, MD
  • Clinical Context: Multiple Myeloma

  • Clinical Context: Multiple Myeloma is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple myeloma.

    The curriculum includes four case studies at the point of care and MedPage Today ...
    more >>
    K. Anderson, MD
  • Clinical Context: Stroke Prevention in Atrial Fibrilation
  • Clinical Context: Stroke Prevention in
    Atrial Fibrillation
    is designed to provide up-to-date information on patient identification, risk factors, and current and emerging treatments and best practices in the management of atrial fibrillation.

    The curriculum includes:
    • 6 case studies
    • MedPage Today meeting
    ...
    more >>
    C. Yancy, MD, MSc
  • Clinical Context: Multiple Sclerosis

  • Clinical Context: Multiple Sclerosis is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple sclerosis.

    The curriculum includes four case studies at the point of care and MedPage ...
    more >>
    P. Coyle, MD
  • Clinical Context: Diabetes
  • Clinical Context: Diabetes is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in diabetes. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that ... more >>
  • Clinical Context: Prostate Cancer
  • Clinical Context: Prostate Cancer is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in prostate cancer. The curriculum includes case studies at the point of care and MedPage Today meeting ... more >>
  • Clinical Context: Diagnosis & Treatment of PBC and NASH

  • Clinical Context: Diagnosis and Treatment of PBC and NASH is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of PBC and NASH.

    The curriculum includes:
    • Case Studies
    • Meeting coverage
    ...
    more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD
  • Multiple Sclerosis: The Advanced Curriculum VII
  • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • Clinical Context: Multiple Myeloma

  • Curriculum In Context: Multiple Myeloma is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple myeloma. The curriculum includes six case studies at the point of care, a webcast, ...
    more >>
    N. Raje, MD
  • MedImage Cases-Neurology: Multiple Sclerosis
  • The MS MedImage Cases® library discusses the MRI as a tool to guide practical therapeutic approaches and measure disease activity, progression, and response to therapy. New collaboration tools: Share Your Knowledge® comment on a particular aspect of a presented case. Share Your Case® €”submit a challenging ... more >>
    D. Pelletier, MD
  • Skin Cancer @Point of Care
  • Skin Cancer @Point of Care platform provides a comprehensive examination of skin cancer clinical pathology and presentation, diagnosis, and the latest evidence-based data for optimizing surgical and treatment strategies for basal cell carcinoma and melanoma. In particular, current and emerging targeted ... more >>
    S. Feldman, MD, PhD
  • Cystic Fibrosis @Point of Care
  • Major advancements, including newborn screening, new treatments targeting the underlying cause of disease, and quality improvement initiatives, have transformed the continuum of care and survival outcomes for individuals with cystic fibrosis. The Cystic Fibrosis @Point of Care Edition provides a comprehensive ... more >>
    S. McColley, MD
  • Chronic Lymphocytic Leukemia @Point of Care
  • Recently approved targeted therapies and emerging immunotherapies for chronic lymphocytic leukemia (CLL) are transforming patient outcomes and the standard of care. To achieve the best patient outcomes, clinicians need to implement individualized treatment plans based upon evaluation of patient ... more >>
    S. Gregory, MD
  • Asthma @Point of Care
  • Asthma @Point of Care™ platform provides a comprehensive knowledge base of current and emerging diagnostic and management strategies based on the most up-to-date scientific data and clinical trial results, guidance, and insights from top clinician specialists all delivered in ways to efficiently and ... more >>
    M. Wechsler, MD, MMSc
  • Idiopathic Pulmonary Fibrosis @Point of Care
  • This point-of-care eTextbook provides a thorough yet concise review of the epidemiology, etiology, and pathophysiology of idiopathic pulmonary fibrosis (IPF), its diagnosis and prognosis, and the latest evidence-based data on current and investigational treatment and management strategies with insights from ... more >>
    M. Padilla, MD
  • Multiple Myeloma @Point of Care
  • This point-of-care eHandbook delivers a thorough yet concise review of multiple myeloma (MM), its diagnosis and prognosis, and the latest evidence-based data on treatment strategies with insights from top clinical specialists on the novel and emerging therapies that are revolutionizing the management of MM. ... more >>
    S. Lonial, MD
  • Asthma @Point of Care
  • Asthma @Point of Care™ platform provides a comprehensive knowledge base of current and emerging diagnostic and management strategies based on the most up-to-date scientific data and clinical trial results, guidance, and insights from top clinician specialists all delivered in ways to efficiently and ... more >>
    M. Wechsler, MD, MMSc
  • Update - Making Sense of New and Emerging Treatment Options for COPD
  • Chronic obstructive pulmonary disease (COPD) is highly prevalent in the United States. About 13 million people have a diagnosis of COPD, yet the disease remains underdiagnosed, with an estimated 21 million individuals affected. Cigarette smoking is the primary cause and, while smoking rates have dropped, they ... more >>
    B. Make, MD
  • Rheumatoid Arthritis @Point of Care
  • Early diagnosis, prompt intervention, and maintenance of tight disease control are now known to be key in preventing or slowing progression of rheumatoid arthritis (RA). Many patients do not achieve or sustain remission with older disease-modifying agents alone. Biologic therapies for RA have helped many ... more >>
    P. Mease, MD
  • Nonalcoholic Steatohepatitis — NASH: Diagnostic and Treatment Breakthroughs – Webcast
  • This 90-minute webcast, from the proceedings of the live symposium in San Francisco, features Program Chair, Dr. Zobair Younossi, and our distinguished faculty, Drs. Stephen Harrison and Rohit Loomba, who will provide expert insight into how novel therapeutic approaches for nonalcoholic steatohepatitis (NASH) ... more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD
  • Primary Biliary Cirrhosis — PBC: Novel Pathways for Treatment of Cholestatic Liver Disease – Webcast
  • Chronic liver diseases are the leading cause of morbidity and mortality in the United States. Since primary biliary cirrhosis (PBC) is a chronic liver disease, it is associated with significant disease burden and unmet medical needs with regard to treatments. There is much excitement today about the ... more >>
    K. Kowdley, MD
  • Diabetes — Advances in Insulin Therapies for the Treatment of T1DM and T2DM – Webcast
  • Determining insulin treatment for patients with type 1 and type 2 diabetes presents a variety of challenges for the physician. In addition to reluctance on the part of patients, and sometimes physicians, to begin insulin, new therapeutic classes and agents – both insulin and non-insulin – have recently ... more >>
    V. Fonseca, MD, FRCP
  • Primary Biliary Cirrhosis — PBC and NASH: Progress on the Horizon – Webcast
  • Chronic liver diseases, such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), are leading causes of morbidity and mortality in the United States. PBC and NASH differ with respect to their epidemiology, presentation, management options, and response to treatment. The burden of these ... more >>
    A. Sanyal, MD
  • Multiple Myeloma — Focus on the Role of Proteasome Inhibitors in the Management of Multiple Myeloma – Webcast
  • Clinicians need to know how to incorporate proteasome inhibitors into treatment plans for patients with multiple myeloma, whether they are newly diagnosed or are experiencing relapsed/refractory disease. Join our co-faculty Sagar Lonial, MD, and Kenneth C. Anderson, MD, for this webcast, Focus on the Role of ... more >>
    S. Lonial, MD
  • Pulmonology — Making Sense of New and Emerging Treatment Options for COPD – Webcast
  • Recent advances have led to important changes in the paradigm for the treatment of COPD. Join Dr. Barry Make and Dr. James Donohue as they discuss the current emphasis on personalized treatment based on expanded factors in patient assessment, together with the development of new and emerging treatment options ... more >>
    B. Make, MD
  • Hepatitis C — Hepatitis C Treatment Goes Viral: Let's Talk About Oral Therapies – Webcast
  • This compelling webcast features expert-guided presentations on the current state of oral therapies for chronic hepatitis C virus (HCV) infection. Learn the implications of clinical trial results, and how the latest advances are affecting today's real-world clinical practice.
    I. Jacobson, MD
  • Primary Biliary Cirrhosis — Changing Dynamics in the Science and Clinical Management of Primary Biliary Cirrhosis: What they Mean for Us, What They Mean for Our Patients – Webcast
  • There are several types of chronic liver disease, including primary biliary cirrhosis (PBC), and there remain several challenges in the management of this disease. Join Dr. David Jones, Program Chair, and Dr. Ulrich Beuers, Distinguished Faculty, as they offer insight into recent developments in the ... more >>
    D. Jones, MD, PhD
  • Multiple Sclerosis — Improving the Management of Walking Impairment and Foot Drop in MS – Webcast
  • Almost two-thirds of MS patients report significant difficulty in walking. Yet, approximately 40% of patients with MS rarely or never discuss this problem with their physicians. As a result of this gap in communication, many MS patients do not experience the benefits of available pharmacologic and ... more >>
    A. Goodman, MD
  • Primary Biliary Cirrhosis — Novel Therapeutic Targets in PBC, PSC, and NASH: Translating Knowledge into Tomorrow's Practice – Webcast
  • There are several types of chronic liver disease, including primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH), and each disease state differs with respect to its epidemiology, presentation, management options, and response to treatment. Management ... more >>
    H. Bodenheimer Jr, MD
  • Gynecologic Cancers — Treatment of Platinum-Resistant Recurrent Ovarian Epithelial Cancer – Case Study
  • Women with recurrent ovarian cancer have limited treatment options and a poor prognosis. This case illustrates the real-life scenario of a woman who experiences platinum-resistant recurrent ovarian cancer and addresses the treatment options, including the use of the targeted antiangiogenic agent bevacizumab, ... more >>
    B. Monk, MD, FACOG, FACS
  • Stroke Prevention — Case Study: Patient with Holiday Heart Syndrome – Case Study
  • This case study in the Clinical Context: Stroke Prevention in Atrial Fibrillation program follows a 51-year-old man with atrial fibrillation that can be attributed to alcohol abuse and/or endurance athletic activity. Whether or not anticoagulation for stroke prevention is indicated is the focus of this ... more >>
    C. Yancy, MD, MSc
  • Multiple Myeloma — Case Study: Role of Immunomodulatory Drug Therapy in a Patient with Refractory Multiple Myeloma – Case Study
  • Today there have been many scientific advances resulting in newly approved treatment options, as well as many more in development, that offer patients with relapsing or refractory multiple myeloma (MM) opportunities to prolong progression-free and overall survival. This case illustrates the real-life scenario ... more >>
    K. Anderson, MD
  • Multiple Sclerosis — Case Study: Primary Progressive Multiple Sclerosis: Patient with Reduced Endurance and Ongoing Deterioration – Case Study
  • While there have been many advances in treatments for patients with relapsing-remitting multiple sclerosis, the development of effective disease-modifying treatments for primary-progressive multiple sclerosis (PPMS) has been more challenging. This case illustrates the real-life scenario of a middle-aged man ... more >>
    P. Coyle, MD
  • Stroke Prevention — Case Study: Patient with Established Atrial Fibrillation – Case Study
  • This case study in the Clinical Context: Stroke Prevention in Atrial Fibrillation program follows an 81-year-old, overweight diabetic male with a remote history of prior myocardial infarction and coronary artery bypass graft with known atrial fibrillation deemed to be “permanent.” He is currently on warfarin ... more >>
    C. Yancy, MD, MSc
  • Primary Biliary Cirrhosis — CASE STUDY: Asymptomatic PBC Patient with Abnormal Biochemical Tests: What Are the Next Steps for Management? – Case Study
  • Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic cholestatic liver disease that predominantly affects middle-aged women. What nonspecific symptoms can help you recognize a patient with PBC? What is the hallmark diagnostic marker? What initial therapy should you ... more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD
  • Nonalcoholic Steatohepatitis — CASE STUDY: Challenges in Managing the Diabetic Patient with Nonalcoholic Steatohepatitis – Case Study
  • Nonalcoholic fatty liver disease encompasses a range of subtypes, with the most important being nonalcoholic steatohepatitis (NASH). Patients with NASH are at high risk for progression to liver-related comorbidities, including cirrhosis, liver cancer, and liver-related death. Given the strong association ... more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD
  • Stroke Prevention — Stroke Prevention in AF: Defining the Low-Risk Patient – Case Study
  • The decision to prescribe oral anticoagulant therapy for stroke prevention in atrial fibrillation (AF) is driven by the underlying estimated risk of stroke if untreated as well as the risk of bleeding on treatment. While anticoagulation is indicated in patients at high risk, the variable risk in patients at ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Stroke Prevention: Managing Nonvalvular AF in a Patient With Valvular Heart Disease – Case Study
  • Non-vitamin K oral anticoagulants (NOACs) are indicated for the prevention of stroke in patients with nonvalvular (vs valvular) atrial fibrillation (AF). But how does one differentiate valvular from nonvalvular AF and are NOACs always contraindicated in patients with valvular heart disease? Join Christopher ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Heart Failure Patient with Atrial Fibrillation, Not Previously Treated – Case Study
  • Since patients with atrial fibrillation face a significant increase in the risk of stroke, determining stroke prophylaxis and identifying patients requiring therapy is a high priority. In this case study, Dr. Yancy discusses the risk factors for stroke in patients with heart failure and atrial fibrillation, ... more >>
    C. Yancy, MD, MSc
  • Primary Biliary Cirrhosis — Profiles in PBC: Management Strategies for the Unmet Medical Need – Satellite Symposium
  • Chronic liver diseases, such as primary biliary cholangitis (PBC), are the leading cause of morbidity and mortality in the United States. PBC is associated with significant disease burden and unmet medical needs with regard to treatments. There is much excitement today within the medical community about ... more >>
    Z. Younossi, MD,MPH,FACG,AGAF,FAASLD